SERPINE1 and cervical carcinoma: The oral administration of PAI-039, a small molecule PAI-1 inhibitor, to mice xenotransplanted with human T24 bladder and HeLa cervical cancer cells resulted in a significant reduction of tumor volume with a decrease in tumor cell proliferation and vascularization and an increase in apoptosis [38].